Familial pancreatic cancer

References

• Lynch HT, Brand RE, Deters CA, Shaw TG, Lynch JF. Hereditary pancreatic cancer. Pancreatology 2001; 1: 466–71
   PubMed Web of Science ®Google Scholar
• Evans JP, Evans JP, Burke W, Chen R, Bennett RL, Schmidt RA, et al. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet 1995; 32: 330–5
   PubMed Web of Science ®Google Scholar
• Lynch HT, Lanspa SJ, Fitzgibbons RJ, Jr, Smyrk T, Fitzsimmons ML, McClellan J. Familial pancreatic cancer (Part 1): genetic pathology review. Nebr Med J 1989; 74: 109–12
   PubMedGoogle Scholar
• Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001; 7: 738–44
   PubMed Web of Science ®Google Scholar
• Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004; 64: 2634–8
   PubMed Web of Science ®Google Scholar
• Lynch HT, Fitzsimmons ML, Smyrk TC, Lanspa SJ, Watson P, McClellan J, et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 1990; 85: 54–60
   PubMed Web of Science ®Google Scholar
• Fernandez E, La Vecchia C, Decarli A. Attributable risks for pancreatic cancer in northern Italy. Cancer Epidemiol Biomarkers Prev 1996; 5: 23–7
   PubMed Web of Science ®Google Scholar
• Ojajärvi IA, Partanen TJ, Ahlbom A, Boffetta P, Hakulinen T, Jourenkova N, et al. Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med 2000; 57: 316–24
   PubMed Web of Science ®Google Scholar
• Neglia JP, FitzSimmons SC, Maisonneuve P, Schöni MH, Schöni-Affolter F, Corey M, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995; 332: 494–9
   PubMed Web of Science ®Google Scholar
• Fernandez E, La Vecchia C, Porta M, Negri E, d'Avanzo B, Boyle P. Pancreatitis and the risk of pancreatic cancer. Pancreas 1995; 11: 185–9
   PubMed Web of Science ®Google Scholar
• Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK, Jr, Perrault J, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997; 89: 442–6
   PubMed Web of Science ®Google Scholar
• Vasen HF, Gruis NA, Frants RR, van Der Velden PA, Hille ET, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809–11
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447–53
   PubMed Web of Science ®Google Scholar
• Lynch HT, Smyrk T, Kern SE, Hruban RH, Lightdale CJ, Lemon SJ, et al. Familial pancreatic cancer: a review. Semin Oncol 1996; 23: 251–75
   PubMed Web of Science ®Google Scholar
• Wong T, Howes N, Threadgold J, Smart HL, Lombard MG, Gilmore I, et al. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients. Pancreatology 2001; 1: 486–509
   PubMed Web of Science ®Google Scholar
• Hisada M, Garber JE, Fung CY, Fraumeni JF, Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998; 90: 606–11
   PubMedGoogle Scholar
• Langer P, Rothmund M, Bartsch DK. Prophylactic pancreas surgery. Chirurgie 2006; 77: 25–32
   Google Scholar
• Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 2003; 103: 525–30
   PubMed Web of Science ®Google Scholar
• Bartsch DK, Kress R, Sina-Frey M, Grützmann R, Gerdes B, Pilarsky C, et al. Prevalence of familial pancreatic cancer in Germany. Int J Cancer 2004; 110: 902–6
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78–85
   PubMed Web of Science ®Google Scholar
• Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003; 124: 1292–9
   PubMed Web of Science ®Google Scholar
• Senior K. Late-onset diabetes and the link with pancreatic cancer. Lancet Oncol 2005; 6: 641
   PubMedGoogle Scholar
• Huxley R, Owen CG, Whincup PH, Cook DG, Colman S, Collins R. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076–83
   PubMed Web of Science ®Google Scholar
• Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir 2004; 59: 99–111
   PubMedGoogle Scholar
• Tarpila E, Borch K, Kullman E, Liedberg G. Pancreatic cancer. Ann Chir Gynaecol 1986; 75: 146–50
   PubMedGoogle Scholar
• Grahm AL, Andren-Sandberg A. Prospective evaluation of pain in exocrine pancreatic cancer. Digestion 1997; 58: 542–9
   PubMed Web of Science ®Google Scholar
• DiMagno EP. Pancreatic cancer: clinical presentation, pitfalls and early clues. Ann Oncol 1999; 10(Suppl 4)140–2
   PubMedGoogle Scholar
• Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 2001; 1: 477–85
   PubMed Web of Science ®Google Scholar
• Bartsch DK, Sina-Frey M, Ziegler A, Hahn SA, Przypadlo E, Kress R, et al. Update of familial pancreatic cancer in Germany. Pancreatology 2001; 1: 510–6
   PubMed Web of Science ®Google Scholar
• Neoptolemos, JP, Lemoine, NR, Ching, CH, Rhodes, JM. Cancer of the pancreas and ampulla of Vater. In: JWL Fielding, Allum, WH. Premalignancy and Early Cancer in General Surgery. Oxford: Oxford Press, 1996; pp 66–100.
   Google Scholar
• Bramhall S, Neoptolemos JP. Epidemiology of pancreatic cancer. The pancreas. Boston: Blackwell Scientific, HG Beger, DL Carr-Locke, RCG Russell, M Büchler, JP Neoptolemos, M Saar, 1998; 889–906
   Google Scholar
• Finch MD, Howes N, Ellis I, Mountford R, Sutton R, Raraty M, et al. Hereditary pancreatitis and familial pancreatic cancer. Digestion 1997; 58: 564–9
   PubMedGoogle Scholar
• Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510–6
   PubMedGoogle Scholar
• Soriano A, Castells A, Ayuso C, Ayuso JR, de Caralt MT, Ginès MA, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004; 99: 492–501
   PubMed Web of Science ®Google Scholar
• Müller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190: 745–51
   PubMed Web of Science ®Google Scholar
• Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 2007; 32: 660–7
   PubMedGoogle Scholar
• Pamuklar E, Semelka RC. MR imaging of the pancreas. Magnetic Res Imaging Clin N Am 2005; 13: 313–30
   PubMedGoogle Scholar
• Michl P, Pauls S, Gress TM. Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 20: 227–51
   PubMed Web of Science ®Google Scholar
• Klapman JB, Chang KJ, Lee JG, Nguyen P. Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol 2005; 100: 2658–61
   PubMed Web of Science ®Google Scholar
• Berberat P, Friess H, Kashiwagi M, Beger HG, Büchler MW. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg 1999; 23: 882–7
   PubMedGoogle Scholar
• Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut 1995; 36: 771–7
   PubMed Web of Science ®Google Scholar
• Stollfuss JC, Glatting G, Friess H, Kocher F, Berger HG, Reske SN. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995; 195: 339–44
   PubMed Web of Science ®Google Scholar
• Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000; 84: 707–18
   PubMedGoogle Scholar
• Mortensen MB, Fristrup C, Holm FS, Pless T, Durup J, Ainsworth AP, et al. Prospective evaluation of patient tolerability, satisfaction with patient information, and complications in endoscopic ultrasonography. Endoscopy 2005; 37: 146–53
   PubMed Web of Science ®Google Scholar
• Voss M, Hammel P, Molas G, Palazzo L, Dancour A, O'Toole D, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut 2000; 46: 244–9
   PubMedGoogle Scholar
• Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 2003; 7: 118–26
   PubMed Web of Science ®Google Scholar
• Gress F, Gottlieb K, Sherman S, Lehman G. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001; 134: 459–64
   PubMed Web of Science ®Google Scholar
• Micames C, Jowell PS, White R, Paulson E, Nelson R, Morse M, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003; 58: 690–5
   PubMed Web of Science ®Google Scholar
• Harewood GC, Wiersema LM, Halling AC, Keeney GL, Salamao DR, Wiersema MJ. Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses. Gastrointest Endosc 2002; 55: 669–73
   PubMed Web of Science ®Google Scholar
• Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999; 44: 720–6
   PubMed Web of Science ®Google Scholar
• Chang KJ, Nguyen P, Erickson RA, Durbin TE, Katz KD. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997; 45: 387–93
   PubMed Web of Science ®Google Scholar
• Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999; 131: 247–55
   PubMed Web of Science ®Google Scholar
• Topazian M, Enders F, Kimmey M, Brand R, Chak A, Clain J, et al. Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc 2007; 66: 62–7
   PubMedGoogle Scholar
• Mertz H, Gautam S. The learning curve for EUS-guided FNA of pancreatic cancer. Gastrointest Endosc 2004; 59: 33–7
   PubMed Web of Science ®Google Scholar
• Kekis PB, Friess H, Kleeff J, Büchler MW. Timing and extent of surgical intervention in patients from hereditary pancreatic cancer kindreds. Pancreatology 2001; 15: 525–30
   Google Scholar
• Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997; 57: 2140–3
   PubMed Web of Science ®Google Scholar
• Löhr M, Maisonneuve P, Lowenfels AB. K-Ras mutations and benign pancreatic disease. Int J Pancreatol 2000; 27: 93–103
   PubMedGoogle Scholar
• Ritts RE, Pitt HA. CA 19-9 in pancreatic cancer. Surg Oncol Clin N Am 1998; 7: 93–101
   PubMedGoogle Scholar
• Malesci A, Tommasini MA, Bonato C, Bocchia P, Bersani M, Zerbi A, et al. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. Gastroenterology 1987; 92: 60–7
   PubMed Web of Science ®Google Scholar
• Pasquali C, Sperti C, D'Andrea AA, Bonadimani B, Del Favero G, Petrin P, et al. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer. Pancreas 1987; 2: 34–7
   PubMedGoogle Scholar
• Benini L, Cavallini G, Zordan D, Rizzotti P, Rigo L, Brocco G, et al. A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer. Pancreas 1988; 3: 61–6
   PubMed Web of Science ®Google Scholar
• Paganuzzi M, Onetto M, Marroni P, Barone D, Conio M, Aste H, et al. CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases. Cancer 1988; 61: 2100–8
   PubMed Web of Science ®Google Scholar
• Alexander JC, Silverman NA, Chretien PB. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA 1976; 235: 1975–9
   PubMed Web of Science ®Google Scholar
• Steinberg WM, Gelfand R, Anderson KK, Glenn J, Kurtzman SH, Sindelar WF, et al. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986; 90: 343–9
   PubMed Web of Science ®Google Scholar
• Kuno N, Kurimoto K, Fukushima M, Hayakawa T, Shibata T, Suzuki T, et al. Effectiveness of multivariate analysis of tumor markers in diagnosis of pancreatic carcinoma: a prospective study in multi-institutions. Pancreas 1994; 9: 725–30
   PubMedGoogle Scholar
• Maitra A, Fukushima N, Takaori K, Hruban RH. Precursors to invasive pancreatic cancer. Adv Anat Pathol 2005; 12: 81–91
   PubMed Web of Science ®Google Scholar
• Canto MI. Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol 2007; 34: 295–302
   PubMedGoogle Scholar
• Brat DJ, Lillemoe KD, Yeo CJ, Warfield PB, Hruban RH. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998; 22: 163–9
   PubMed Web of Science ®Google Scholar
• Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976; 36: 2690–8
   PubMed Web of Science ®Google Scholar
• Brune K, Abe T, Canto M, O'Malley L, Klein AP, Maitra A, et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006; 30: 1067–76
   PubMed Web of Science ®Google Scholar
• Schwartz AM, Henson DE. Familial and sporadic pancreatic carcinoma, epidemiologic concordance. Am J Surg Pathol 2007; 31: 645–6
   PubMedGoogle Scholar
• Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17–32
   PubMed Web of Science ®Google Scholar
• Pelaez-Luna M, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007; 102: 1759–64
   PubMed Web of Science ®Google Scholar
• Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?. Gut 2007; 56: 1086–90
   PubMed Web of Science ®Google Scholar
• Schmidt CM, Lillemoe KD. IPMN-controversies in an “epidemic”. J Surg Oncol 2006; 94: 91–3
   PubMedGoogle Scholar
• Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28: 977–87
   PubMed Web of Science ®Google Scholar
• Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003; 16: 996–1006
   PubMed Web of Science ®Google Scholar
• Brentnall TA. Management strategies for patients with hereditary pancreatic cancer. Curr Treat Options Oncol 2005; 6: 437–45
   PubMedGoogle Scholar
• Billings BJ, Christein JD, Harmsen WS, Harrington JR, Chari ST, Que FG, et al. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?. J Gastrointest Surg 2005; 9: 1059–66
   PubMed Web of Science ®Google Scholar
• Dresler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg 1991; 214: 131–40
   PubMed Web of Science ®Google Scholar
• Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol 2004; 18: 947–55
   PubMedGoogle Scholar
• Rieder H, Bartsch DK. Familial pancreatic cancer. Fam Cancer 2004; 3: 69–74
   PubMedGoogle Scholar
• Charpentier KP, Brentnall TA, Bronner MP, Byrd D, Marsh C. A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clin Transplant 2004; 18: 105–7
   PubMedGoogle Scholar
• Rulyak SJ, Kimmey MB, Veenstra DL, Brentnall TA. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 2003; 57: 23–9
   PubMed Web of Science ®Google Scholar
• van der Maas PJ, de Koning HJ, van Ineveld BM, van Oortmarssen GJ, Habbema JD, Lubbe KT, et al. The cost-effectiveness of breast cancer screening. Int J Cancer 1989; 43: 1055–60
   PubMed Web of Science ®Google Scholar
• Provenzale D. Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin N Am 2002; 12: 93–109
   PubMedGoogle Scholar
• Olsen KR, Bojesen SE, Gerdes AM, Lindorff-Larsen K, Bernstein IT. Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer. Int J Technol Assess Health Care 2007; 23: 89–95
   PubMed Web of Science ®Google Scholar
• Latchford A, Greenhalf W, Vitone LJ, Neoptolemos JP, Lancaster GA, Phillips RK. Peutz-Jeghers syndrome and screening for pancreatic cancer. Br J Surg 2006; 93: 1446–55
   PubMedGoogle Scholar